Trial Profile
Chronification and reversibility of migraine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Apr 2022
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Migraine; Secondary headache disorders; Tension type headache
- Focus Therapeutic Use
- Acronyms CHARM
- 01 May 2022 Results published in the European Journal of Neurology
- 10 Sep 2017 The results are currently being analysed and will be presented at the meeting as per trial design presented at the 2017 International Headache Society
- 10 Sep 2017 Trial design presented at the 2017 International Headache Society